MR/TRUS Fusion Guided Prostate Biopsy

Status unconfirmed · Not applicable

Conditions studied: Prostate Disease, Elevated Prostate Specific Antigen, Family History of Prostate Cancer, Positive Digital Rectal Exam

In brief

This study will determine if targeted (Magnetic Resonance (MR) / Ultrasound (US) fusion biopsy) plus conventional biopsy is superior to conventional biopsy alone in diagnosing subjects with prostate cancer.

Key facts

Study ID
NCT04026763
Run by
Icahn School of Medicine at Mount Sinai
People needed
520
Starts
2018-05-11
Expected to finish
2021-12-01
Last updated by the study team
2019-07-19

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.